Maria Sandri, DPhil - Publications

Affiliations: 
1992-1996 University of Oxford, Oxford, United Kingdom 

42/187 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Clerico A, Cardinale DM, Zaninotto M, Aspromonte N, Sandri MT, Passino C, Migliardi M, Perrone M, Fortunato A, Padoan A, Trenti T, Bernardini S, Sciacovelli L, Colivicchi F, Gabrielli D, et al. High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy. Clinical Chemistry and Laboratory Medicine. 59: 513-521. PMID 32441665 DOI: 10.1515/cclm-2020-0362  0.316
2020 Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, et al. Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project. World Journal of Urology. 38: 2215-2220. PMID 31691083 DOI: 10.1007/s00345-019-03002-3  0.304
2019 Cristofanilli M, Pierga JY, Reuben J, Rademaker A, Davis AA, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Giuliano M, Garcia-Saenz JA, Stebbing J, Caldas C, ... ... Sandri MT, et al. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. Critical Reviews in Oncology/Hematology. 134: 39-45. PMID 30771872 DOI: 10.1016/J.Critrevonc.2018.12.004  0.529
2018 Gioffre' S, Chiesa M, Alfieri I, Masson S, Latini R, Sandri MT, Cardinale D, Pompilio G, Colombo GI, D'Alessandra Y. P4763Circulating microRNAs as selective markers of anthracyclines-based therapies in breast cancer patients European Heart Journal. 39. DOI: 10.1093/EURHEARTJ/EHY563.P4763  0.393
2016 Aurilio G, Sandri MT, Pruneri G, Zorzino L, Botteri E, Munzone E, Adamoli L, Facchi G, Cullurà D, Verri E, Rocca MC, Zurrida S, Iacovelli R, Nolè F. Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer. Future Oncology (London, England). 12: 2001-8. PMID 27255717 DOI: 10.2217/fon-2016-0081  0.428
2016 Salvatici M, Achilarre MT, Sandri MT, Boveri S, Vanna Z, Landoni F. Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: Role in the early diagnosis of recurrence. Gynecologic Oncology. 142: 115-119. PMID 27117922 DOI: 10.1016/j.ygyno.2016.04.029  0.323
2016 Bidard F, Peeters D, Fehm T, Nole F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz J, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Lascoiti AFd, ... ... Sandri M, et al. Abstract P2-08-08: Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-08-08  0.508
2015 Balduzzi A, Bagnardi V, Sandri MT, Dellapasqua S, Cardillo A, Montagna E, Cancello G, Iorfida M, Ghisini R, Viale G, Intra M, Luini A, Goldhirsch A, Colleoni M. Intermittent Letrozole Administration as Adjuvant Endocrine Therapy for Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer: A Biologic Study. Clinical Breast Cancer. 15: e257-62. PMID 26362840 DOI: 10.1016/j.clbc.2015.03.007  0.383
2015 Bissolati M, Sandri MT, Burtulo G, Zorzino L, Balzano G, Braga M. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 991-6. PMID 25318603 DOI: 10.1007/s13277-014-2716-0  0.362
2014 Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A, Andergassen U, Meier-Stiegen F, Czyz ZT, Alberter B, Treitschke S, Schamberger T, Sergio M, Bregola G, Doffini A, ... ... Sandri MT, et al. Molecular profiling of single circulating tumor cells with diagnostic intention. Embo Molecular Medicine. 6: 1371-86. PMID 25358515 DOI: 10.15252/emmm.201404033  0.34
2014 Magni E, Botteri E, Ravenda PS, Cassatella MC, Bertani E, Chiappa A, Luca F, Zorzino L, Bianchi PP, Adamoli L, Sandri MT, Zampino MG. Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery. International Journal of Colorectal Disease. 29: 1053-9. PMID 25008360 DOI: 10.1007/s00384-014-1958-z  0.383
2014 Ignatiadis M, Riethdorf S, Bidard FC, Vaucher I, Khazour M, Rothé F, Metallo J, Rouas G, Payne RE, Coombes R, Teufel I, Andergassen U, Apostolaki S, Politaki E, Mavroudis D, ... ... Sandri M, et al. International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Research : Bcr. 16: R43. PMID 24758318 DOI: 10.1186/bcr3647  0.421
2014 Salvatici M, Cardinale D, Botteri E, Bagnardi V, Mauro C, Cassatella MC, Lentati P, Bottari F, Zorzino L, Passerini R, Cipolla CM, Sandri MT. TnI-Ultra assay measurements in cancer patients: comparison with the conventional assay and clinical implication. Scandinavian Journal of Clinical and Laboratory Investigation. 74: 385-91. PMID 24693994 DOI: 10.3109/00365513.2014.898325  0.328
2014 Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, ... ... Sandri MT, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. The Lancet. Oncology. 15: 406-14. PMID 24636208 DOI: 10.1016/S1470-2045(14)70069-5  0.541
2014 Campiglio M, Sandri M, Sasso M, Bianchi F, Balsari A, Ménard S, Tagliabue E. Prognostic role of tumor size in T1 HER2-positive breast cancers treated with adjuvant trastuzumab. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: 1073-4. PMID 24558025 DOI: 10.1093/annonc/mdu058  0.364
2013 Yahalom G, Weiss D, Novikov I, Bevers TB, Radvanyi LG, Liu M, Piura B, Iacobelli S, Sandri MT, Cassano E, Allweis TM, Bitterman A, Engelman P, Vence LM, Rosenberg MM. An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis. Biomarkers in Cancer. 5: 71-80. PMID 24324350 DOI: 10.4137/BIC.S13236  0.314
2013 Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, Macis D, Puccio A, Sandri MT, Gulisano M, Formelli F, Decensi A. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide. Breast Cancer Research and Treatment. 142: 569-78. PMID 24241787 DOI: 10.1007/s10549-013-2768-7  0.339
2013 Cassatella MC, Zorzino L, Sandri MT. Single circulating tumor cell profiling: a new perspective for targeted therapy? Future Oncology (London, England). 8: 1253-6. PMID 23130926 DOI: 10.2217/fon.12.119  0.384
2013 Bidard F, Peeters D, Fehm T, Nole F, Gisbert-Criado R, Mavrudis D, Grisanti S, Generali D, Garcia-Saenz J, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Antelo M, ... ... Sandri M, et al. Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-Pd6-5  0.548
2012 Munzone E, Botteri E, Sandri MT, Esposito A, Adamoli L, Zorzino L, Sciandivasci A, Cassatella MC, Rotmensz N, Aurilio G, Curigliano G, Goldhirsch A, Nolè F. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer. Clinical Breast Cancer. 12: 340-6. PMID 23040002 DOI: 10.1016/j.clbc.2012.07.001  0.418
2012 Dellapasqua S, Bagnardi V, Bertolini F, Sandri MT, Pastrello D, Cancello G, Montagna E, Balduzzi A, Mancuso P, Luini A, Goldhirsch A, Colleoni M. Increased mean corpuscular volume of red blood cells predicts response to metronomic capecitabine and cyclophosphamide in combination with bevacizumab. Breast (Edinburgh, Scotland). 21: 309-13. PMID 22341133 DOI: 10.1016/j.breast.2012.01.015  0.383
2012 Aurilio G, Sciandivasci A, Munzone E, Sandri MT, Zorzino L, Cassatella MC, Verri E, Rocca MC, Nolè F. Prognostic value of circulating tumor cells in primary and metastatic breast cancer. Expert Review of Anticancer Therapy. 12: 203-14. PMID 22316368 DOI: 10.1586/era.11.208  0.428
2012 Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, et al. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 151-7. PMID 22162577 DOI: 10.1200/JCO.2011.35.2237  0.35
2012 Aurilio G, Munzone E, Botteri E, Pedroli S, Sandri M, Adamoli L, Zorzino L, Sciandivasci A, Esposito A, Nolè F. 41P Circulating Tumor Cells (CTCs) and Metronomic Oral Vinorelbine (OV) in Advanced Breast Cancer (ABC) Patients (PTS): Exploratory Prospective Analysis Annals of Oncology. 23: ii26. DOI: 10.1016/s0923-7534(19)65694-2  0.433
2011 Liu MC, Mego M, Nakamura S, Nole F, Pierga J, Toi M, Munzone E, Yagata H, Sandri MT, Bidard F, Wang H, Hayes DF, Cristofanilli M. Clinical validity of circulating tumor cell (CTC) enumeration in 841 subjects with metastatic breast cancer (MBC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 10592. PMID 28021972 DOI: 10.1200/jco.2011.29.15_suppl.10592  0.376
2011 Fontana F, Bonizzi G, Medoro G, Zorzino L, Sergio M, Cassatella MC, Peruzzi E, Gianni S, Calanca A, Signorini G, Nole F, Giorgini G, Munzone E, Manaresi N, Sandri MT. Sequencing the chemokine receptor CXCR4 in individual circulating tumor cells (CTCs) of patients with breast cancer (BrCa). Journal of Clinical Oncology. 29: e21134-e21134. DOI: 10.1200/JCO.2011.29.15_SUPPL.E21134  0.399
2010 Munzone E, Nolé F, Goldhirsch A, Botteri E, Esposito A, Zorzino L, Curigliano G, Minchella I, Adamoli L, Cassatella MC, Casadio C, Sandri MT. Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer. Clinical Breast Cancer. 10: 392-7. PMID 20920984 DOI: 10.3816/CBC.2010.n.052  0.314
2010 Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M, Lamantia G, Colombo N, Cortinovis S, Dessanai MA, Nolè F, Veglia F, Cipolla CM. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3910-6. PMID 20679614 DOI: 10.1200/JCO.2009.27.3615  0.328
2010 Sandri MT, Zorzino L, Cassatella MC, Bassi F, Luini A, Casadio C, Botteri E, Rotmensz N, Adamoli L, Nolè F. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Annals of Surgical Oncology. 17: 1539-45. PMID 20135356 DOI: 10.1245/s10434-010-0918-2  0.455
2010 Alunni-Fabbroni M, Sandri MT. Circulating tumour cells in clinical practice: Methods of detection and possible characterization. Methods (San Diego, Calif.). 50: 289-97. PMID 20116432 DOI: 10.1016/j.ymeth.2010.01.027  0.323
2010 Botteri E, Sandri MT, Bagnardi V, Munzone E, Zorzino L, Rotmensz N, Casadio C, Cassatella MC, Esposito A, Curigliano G, Salvatici M, Verri E, Adamoli L, Goldhirsch A, Nolè F. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Research and Treatment. 122: 211-7. PMID 19967556 DOI: 10.1007/s10549-009-0668-7  0.484
2009 Rocca A, Cancello G, Bagnardi V, Sandri MT, Torrisi R, Zorzino L, Viale G, Pietri E, Veronesi P, Dellapasqua S, Ferrucci F, Luini A, Johansson H, Ghisini R, Goldhirsch A, et al. Perioperative serum VEGF and extracellular domains of EGFR and HER2 in early breast cancer. Anticancer Research. 29: 5111-9. PMID 20044624  0.391
2009 Contino G, Bertani E, Zampino G, Zorzino L, Magni E, Andreoni B, Sandri M, Chiappa A. P10 Detection of circulating tumor cells (CTCs) in Stage cT3–4orN+ rectal cancer patients (pts) undergoing combined neoadjuvant therapy plus curative surgery. Preliminary data European Journal of Cancer Supplements. 7: 35. DOI: 10.1016/S1359-6349(09)72226-8  0.32
2008 Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Research and Treatment. 108: 57-67. PMID 17468953 DOI: 10.1007/s10549-007-9577-9  0.317
2008 Munzone E, Nolé F, Zorzino L, Medici M, Minchella I, Cassatella MC, Casadio C, Picozzi M, Adamoli L, Goldhirsch A, Sandri M. Acquisition of HER2/neu over-expression on circulating tumor cells (CTCs) in patients (pts) with advanced breast cancer (ABC) during chemotherapy Journal of Clinical Oncology. 26: 11017-11017. DOI: 10.1200/JCO.2008.26.15_SUPPL.11017  0.421
2007 Nolé F, Munzone E, Zorzino L, Minchella I, Salvatici M, Botteri E, Medici M, Verri E, Adamoli L, Rotmensz N, Goldhirsch A, Sandri MT. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 19: 891-7. PMID 18056915 DOI: 10.1093/ANNONC/MDM558  0.464
2007 Sandri MT, Johansson HA, Zorzino L, Salvatici M, Passerini R, Maisonneuve P, Rocca A, Peruzzotti G, Colleoni M. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy. Cancer. 110: 509-17. PMID 17559147 DOI: 10.1002/cncr.22825  0.444
2005 Colleoni M, Orlando L, Sanna G, Rocca A, Maisonneuve P, Peruzzotti G, Ghisini R, Sandri MT, Zorzino L, Nolè F, Viale G, Goldhirsch A. Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 17: 232-8. PMID 16322118 DOI: 10.1093/ANNONC/MDJ066  0.347
2005 Intra M, Gentilini O, Brenelli F, Chagas EM, Veronesi U, Sandri MT. Breast cancer among HIV-infected patients: the experience of the European Institute of Oncology. Journal of Surgical Oncology. 91: 141-2. PMID 16028288 DOI: 10.1002/JSO.20315  0.303
2004 Sandri MT, Johansson H, Colleoni M, Zorzino L, Passerini R, Orlando L, Viale G. Serum levels of HER2 ECD can determine the response rate to low dose oral cyclophosphamide and methotrexate in patients with advanced stage breast carcinoma. Anticancer Research. 24: 1261-6. PMID 15154657  0.406
2004 Colleoni M, Curigliano G, Minchella I, Peruzzotti G, Nolè F, Mazzarol G, Renne G, Orlando L, Rocca A, Veronesi P, Intra M, Viale G, Sandri MT, Severi G, Goldhirsch A. Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 14: 1477-83. PMID 14504046 DOI: 10.1093/ANNONC/MDG411  0.347
2003 Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, et al. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. Journal of the National Cancer Institute. 95: 779-90. PMID 12783932 DOI: 10.1093/JNCI/95.11.779  0.32
Low-probability matches (unlikely to be authored by this person)
2010 Chiappa A, Bertani E, Zampino M, Sandri M, Barsalini C, Andreoni B. Detection of circulating tumor cells (CTCs) in locally advanced rectal cancer. Preliminary Results European Journal of Surgical Oncology (Ejso). 36: 1102. DOI: 10.1016/J.EJSO.2010.08.115  0.295
2009 Nole F, Munzone E, Bertolini F, Sandri MT, Petralia G, Adamoli L, Radice D, Cullura D, di Pietro A, Goldhirsch A. Circulating endothelial cells (CECs), progenitors (CEPs), and circulating tumor cells (CTCs) for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic oral vinorelbine (oV): Preliminary results Journal of Clinical Oncology. 27: e14572-e14572. DOI: 10.1200/JCO.2009.27.15_SUPPL.E14572  0.291
2002 Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nolè F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A. Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 73-80. PMID 11863115 DOI: 10.1093/ANNONC/MDF013  0.289
2018 Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, ... ... Sandri MT, et al. Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients. Urologia Internationalis. 1-8. PMID 30408799 DOI: 10.1159/000494259  0.285
2002 Cardinale D, Sandri MT, Martinoni A, Borghini E, Civelli M, Lamantia G, Cinieri S, Martinelli G, Fiorentini C, Cipolla CM. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 13: 710-5. PMID 12075738 DOI: 10.1093/ANNONC/MDF170  0.285
2015 Salvatici M, Sandri MT. Identifying cancer patients at risk for cardiotoxicity. Future Oncology (London, England). 11: 2077-91. PMID 26198838 DOI: 10.2217/fon.15.69  0.283
2011 Gervasoni A, Sandri MT, Nascimbeni R, Zorzino L, Cassatella MC, Baglioni L, Panigara S, Gervasi M, Di Lorenzo D, Parolini O. Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients. Oncology Reports. 25: 1669-703. PMID 21455578 DOI: 10.3892/or.2011.1231  0.281
2005 Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Research and Treatment. 88: 63-73. PMID 15538047 DOI: 10.1007/s10549-004-0746-9  0.28
2018 Cardinale D, Ciceri F, Latini R, Franzosi MG, Sandri MT, Civelli M, Cucchi G, Menatti E, Mangiavacchi M, Cavina R, Barbieri E, Gori S, Colombo A, Curigliano G, Salvatici M, et al. Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial. European Journal of Cancer (Oxford, England : 1990). 94: 126-137. PMID 29567630 DOI: 10.1016/j.ejca.2018.02.005  0.28
2004 Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 109: 2749-54. PMID 15148277 DOI: 10.1161/01.CIR.0000130926.51766.CC  0.276
2001 Zurrida S, Galimberti V, Gibelli B, Luini A, Gianoglio S, Sandri MT, Passerini R, Maisonneuve P, Zucali P, Jeronesi G, Pigatto F, Veronesi U. Timing of breast cancer surgery in relation to the menstrual cycle: an update of developments. Critical Reviews in Oncology/Hematology. 38: 223-30. PMID 11369255 DOI: 10.1016/S1040-8428(00)00128-1  0.274
2012 Sandri MT, Salvatici M, Botteri E, Passerini R, Zorzino L, Rotmensz N, Luini A, Mauro C, Bagnardi V, Cassatella MC, Bottari F, Casadio C, Colleoni M. Prognostic role of CA15.3 in 7942 patients with operable breast cancer. Breast Cancer Research and Treatment. 132: 317-26. PMID 22065291 DOI: 10.1007/s10549-011-1863-x  0.267
2015 Verri E, Aurilio G, Cossu Rocca M, Sandri M, Pruneri G, Botteri E, Zorzino L, Cassatella C, Adamoli L, Cullurà D, De Cobelli O, Musi G, Jereczek B, Iacovelli R, Nolè F. Clinical outcome of circulating tumor cells in metastatic castration-resistant prostate cancer patients treated with docetaxel: long-term prospective single-centre study Annals of Oncology. 26: vi55. DOI: 10.1093/annonc/mdv341.10  0.265
2012 Passerini R, Cassatella MC, Boveri S, Salvatici M, Radice D, Zorzino L, Galli C, Sandri MT. The pitfalls of CA19-9: Routine testing and comparison of two automated immunoassays in a reference oncology center American Journal of Clinical Pathology. 138: 281-287. PMID 22904141 DOI: 10.1309/AJCPOPNPLLCYR07H  0.263
2017 Cardinale D, Biasillo G, Salvatici M, Sandri MT, Cipolla CM. Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy. Expert Review of Molecular Diagnostics. 17: 245-256. PMID 28092472 DOI: 10.1080/14737159.2017.1283219  0.261
2005 Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, et al. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 4389-97. PMID 15240527 DOI: 10.1158/1078-0432.CCR-04-0087  0.261
2013 Zampino MG, Magni E, Ravenda SP, Botteri E, Bertani E, Chiappa A, Valvo M, Zorzino L, Adamoli L, Nole F, Sandri MT. Detection of circulating tumor cells (CTCs) in stage T3-4 and/or N positive rectal cancer (RC) patients undergoing neoadjuvant therapy followed by curative surgery. Journal of Clinical Oncology. 31: e22078-e22078. DOI: 10.1200/JCO.2013.31.15_SUPPL.E22078  0.259
2014 Colombo A, Sandri MT, Salvatici M, Cipolla CM, Cardinale D. Cardiac complications of chemotherapy: role of biomarkers. Current Treatment Options in Cardiovascular Medicine. 16: 313. PMID 24771223 DOI: 10.1007/s11936-014-0313-6  0.256
2009 Chiappa A, Contino G, Bertani E, Bianchi P, Zampino M, Sandri M, Magni E, Branchi V, Corbellini C, Andreoni B. 1324 Detection of circulating tumour cells in locally advanced colorectal cancer: preliminary data European Journal of Cancer Supplements. 7: 146. DOI: 10.1016/S1359-6349(09)70497-5  0.256
2010 Cardinale D, Sandri MT. Role of biomarkers in chemotherapy-induced cardiotoxicity. Progress in Cardiovascular Diseases. 53: 121-9. PMID 20728699 DOI: 10.1016/j.pcad.2010.04.002  0.25
2010 Noberasco C, Spitaleri G, Mancuso P, Zorzino L, Radice D, Milani A, Rocca A, Bertolini F, Sandri MT, Curigliano G, De Pas T, Jemos C, Omodeo Salè E, Boselli S, De Braud F. Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents Oncology. 77: 358-365. DOI: 10.1159/000275830  0.248
1998 Decensi A, Bonanni B, Guerrieri-Gonzaga A, Gandini S, Robertson C, Johansson H, Travaglini R, Sandri MT, Tessadrelli A, Farante G, Salinaro F, Bettega D, Barreca A, Boyle P, Costa A, et al. Biologic activity of tamoxifen at low doses in healthy women. Journal of the National Cancer Institute. 90: 1461-7. PMID 9776411 DOI: 10.1093/jnci/90.19.1461  0.247
2020 Personeni N, Mineri R, Michelini A, Bozzarelli S, Pressiani T, Smiroldo V, Sandri MT, Giordano L, Santoro A, Rimassa L. Do irinotecan (IRI) dose reductions driven by UGT1A1*28 genotyping prevent IRI-related severe neutropenia? A real-world study. Journal of Clinical Oncology. 38: e16116-e16116. DOI: 10.1200/jco.2020.38.15_suppl.e16116  0.247
2013 Serrano D, Lazzeroni M, Gandini S, Macis D, Johansson H, Gjerde J, Lien E, Feroce I, Pruneri G, Sandri M, Bassi F, Brenelli F, Luini A, Cazzaniga M, Varricchio C, et al. A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer. Breast Cancer Research : Bcr. 15: R47. PMID 23786776 DOI: 10.1186/bcr3439  0.243
2004 Veronesi G, Pelosi G, Sonzogni A, Leon ME, D'Aiuto M, Gasparri R, De Braud F, De Pas T, Sandri M, Spaggiari L. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung. Lung Cancer (Amsterdam, Netherlands). 48: 233-40. PMID 15829323 DOI: 10.1016/J.LUNGCAN.2004.10.018  0.243
2013 Sandri MT, Salvatici M, Mauro C, Radice D, Lentati P, Massaro MA, Boveri S, Zorzino L, Landoni F. Detection of squamous cell carcinoma antigen with two systems in the follow-up of patients with cervical cancer. The International Journal of Biological Markers. 28: 313-317. PMID 23722302 DOI: 10.5301/jbm.5000031  0.239
2010 Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. European Journal of Cancer (Oxford, England : 1990). 46: 3345-50. PMID 20833034 DOI: 10.1016/j.ejca.2010.08.009  0.237
2016 Cardinale D, Sandri MT, Colombo A, Salvatici M, Tedeschi I, Bacchiani G, Beggiato M, Meroni CA, Civelli M, Lamantia G, Colombo N, Veglia F, Casiraghi M, Spaggiari L, Venturino M, et al. Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery: The PRESAGE Trial. Annals of Surgery. PMID 26764872 DOI: 10.1097/SLA.0000000000001626  0.235
2023 Clerico A, Zaninotto M, Aimo A, Cardinale DM, Dittadi R, Sandri MT, Perrone MA, Belloni L, Fortunato A, Trenti T, Plebani M. Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance. Clinical Chemistry and Laboratory Medicine. PMID 36695506 DOI: 10.1515/cclm-2022-1285  0.234
2006 Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. [Biochemical markers for predicting chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use]. Giornale Italiano Di Cardiologia (2006). 7: 604-11. PMID 17128782  0.233
2006 Johansson H, Bonanni B, Mariette F, Cazzaniga M, Baglietto L, Guerrieri-Gonzaga A, Sandri MT, Luini A, Pelosi G, Decensi A. Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer. Breast Cancer Research and Treatment. 98: 167-72. PMID 16538534 DOI: 10.1007/s10549-005-9145-0  0.227
2006 Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Martinelli G, Veglia F, Fiorentini C, Cipolla CM. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation. 114: 2474-81. PMID 17101852 DOI: 10.1161/CIRCULATIONAHA.106.635144  0.226
2020 Gioffré S, Chiesa M, Cardinale DM, Ricci V, Vavassori C, Cipolla CM, Masson S, Sandri MT, Salvatici M, Ciceri F, Latini R, Staszewsky LI, Pompilio G, Colombo GI, D'Alessandra Y. Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin. Journal of Clinical Medicine. 9. PMID 32403263 DOI: 10.3390/jcm9051418  0.226
2013 Sandri MT, Bottari F, Franchi D, Boveri S, Candiani M, Ronzoni S, Peiretti M, Radice D, Passerini R, Sideri M. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: Correlation with pathological outcome Gynecologic Oncology. 128: 233-238. PMID 23200911 DOI: 10.1016/j.ygyno.2012.11.026  0.222
2009 Cossu RM, Verri E, Sandri M, Marenghi C, Botteri E, Adamoli L, Curigliano G, De Cobelli O, Rocco B, Zorzino L, Cassatella M, Nolè F. 701 IMMUNOMAGNETIC QUANTIFICATION OF CIRCULATING TUMOUR CELLS (CTCS) AS NEW PROGNOSTIC AND PREDICTIVE FACTOR IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PRELIMINARY RESULTS European Urology Supplements. 8: 296. DOI: 10.1016/S1569-9056(09)60695-3  0.221
2014 Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, et al. Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014). Ecancermedicalscience. 8: 433. PMID 24932213 DOI: 10.3332/Ecancer.2014.433  0.217
2020 Meessen JMTA, Cardinale D, Ciceri F, Sandri MT, Civelli M, Bottazzi B, Cucchi G, Menatti E, Mangiavacchi M, Condorelli G, Barbieri E, Gori S, Colombo A, Curigliano G, Salvatici M, et al. Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS-ONE trial. Esc Heart Failure. PMID 32358917 DOI: 10.1002/ehf2.12695  0.214
2008 Sandri MT, Passerini R, Leon ME, Peccatori FA, Zorzino L, Salvatici M, Riggio D, Cassatella C, Cinieri S, Martinelli G. Procalcitonin as a useful marker of infection in hemato-oncological patients with fever. Anticancer Research. 28: 3061-5. PMID 19031957  0.214
2008 Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. American Journal of Clinical Pathology. 130: 688-95. PMID 18854260 DOI: 10.1309/AJCPB66LRIIVMQDR  0.21
2022 Personeni N, Giordano L, Michelini A, D'Alessio A, Cammarota A, Bozzarelli S, Pressiani T, Prete MG, Sandri MT, Stioui S, Germagnoli L, Santoro A, Rimassa L, Mineri R. Implementing Pre-Therapeutic Genotyping in Clinical Practice: A Real-Life Study. Journal of Personalized Medicine. 12. PMID 35207692 DOI: 10.3390/jpm12020204  0.204
2011 Cardinale D, Salvatici M, Sandri MT. Role of biomarkers in cardioncology. Clinical Chemistry and Laboratory Medicine. 49: 1937-48. PMID 21892906 DOI: 10.1515/CCLM.2011.692  0.203
2018 Cardinale D, Cosentino N, Moltrasio M, Sandri MT, Petrella F, Colombo A, Bacchiani G, Tessitore A, Bonomi A, Veglia F, Salvatici M, Cipolla CM, Marenzi G, Spaggiari L. Acute kidney injury after lung cancer surgery: Incidence and clinical relevance, predictors, and role of N-terminal pro B-type natriuretic peptide. Lung Cancer (Amsterdam, Netherlands). 123: 155-159. PMID 30089588 DOI: 10.1016/j.lungcan.2018.07.009  0.203
2020 Salvatici M, Barbieri B, Cioffi SMG, Morenghi E, Leone FP, Maura F, Moriello G, Sandri MT. Association between cardiac troponin I and mortality in patients with COVID-19. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 25: 634-640. PMID 33003961 DOI: 10.1080/1354750X.2020.1831609  0.202
2010 Salvatici M, Cardinale D, Spaggiari L, Veglia F, Tedesco CC, Solli P, Cipolla CM, Zorzino L, Passerini R, Riggio D, Cassatella MC, Sandri MT. Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 15: 259-65. PMID 20030573 DOI: 10.3109/13547500903509351  0.2
2003 Sandri MT, Cardinale D, Zorzino L, Passerini R, Lentati P, Martinoni A, Martinelli G, Cipolla CM. Minor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy. Clinical Chemistry. 49: 248-52. PMID 12560347 DOI: 10.1373/49.2.248  0.2
2015 Origoni M, Cristoforoni P, Carminati G, Stefani C, Costa S, Sandri MT, Mariani L, Preti M. E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective. Ecancermedicalscience. 9: 533. PMID 26015802 DOI: 10.3332/ecancer.2015.533  0.199
2019 Mauro C, Passerini R, Spaggiari L, Galetta D, Radice D, Lentati P, Sandri MT. New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1. The International Journal of Biological Markers. 34: 163-167. PMID 30994045 DOI: 10.1177/1724600819834235  0.197
2019 Bonde JH, Sandri MT, Gary DS, Andrews JC. Clinical Utility of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Systematic Review. Journal of Lower Genital Tract Disease. PMID 31714325 DOI: 10.1097/LGT.0000000000000494  0.196
2008 De Cicco C, Ravasi L, Zorzino L, Sandri MT, Botteri E, Verweij F, Granchi D, de Cobelli O, Paganelli G. Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancer. Current Cancer Drug Targets. 8: 199-206. PMID 18473733 DOI: 10.2174/156800908784293613  0.194
2004 Bonanni B, Johansson H, Gandini S, Guerrieri-Gonzaga A, Sandri MT, Mariette F, Lien EA, Decensi A. Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women. Journal of Thrombosis and Haemostasis : Jth. 1: 2149-52. PMID 14521597 DOI: 10.1046/j.1538-7836.2003.00392.x  0.191
2022 Clerico A, Zaninotto M, Aimo A, Musetti V, Perrone M, Padoan A, Dittadi R, Sandri MT, Bernardini S, Sciacovelli L, Trenti T, Malloggi L, Moretti M, Burgio MA, Manno ML, et al. Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers. A consensus document by the Inter-Society Study Group on Cardiac Biomarkers of the Italian Societies of Clinical Biochemistry: European Ligand Assay Society (ELAS), Italian section; Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC); Società Italiana di Patologia Clinica e Medicina di Laboratorio (SIPMel). Clinical Chemistry and Laboratory Medicine. PMID 35858238 DOI: 10.1515/cclm-2022-0481  0.19
2015 Costa S, Sideri M, Negri G, Venturoli S, Santini D, Casadio C, Sandri MT, Bucchi L. The predictive value of human papillomavirus testing for the outcome of patients conservatively treated for stage IA squamous cell cervical carcinoma. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 70: 53-7. PMID 26305820 DOI: 10.1016/j.jcv.2015.07.007  0.182
2010 Cipolla CM, Colombo A, Torrisi R, Sandri MT, Civelli M, Lamantia G, Colombo N, Salvatici M, Cortinovis S, Dessanai MA, Nole’ F, Veglia F, Cardinale D. CLINICAL AND PROGNOSTIC IMPLICATIONS OF EARLY TROPONIN I INCREASE IN TRASTUZUMAB INDUCED CARDIOTOXICITY. Journal of the American College of Cardiology. 55: A34.E332. DOI: 10.1016/S0735-1097(10)60333-6  0.182
2000 Decensi A, Gandini S, Guerrieri-Gonzaga A, Johansson H, Manetti L, Bonanni B, Sandri MT, Barreca A, Costa A, Robertson C, Lien EA. Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction in healthy women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 2633-8. PMID 10561336 DOI: 10.1200/JCO.1999.17.9.2633  0.181
2016 Mariani L, Sandri MT, Preti M, Origoni M, Costa S, Cristoforoni P, Bottari F, Sideri M. HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions. Journal of Cancer. 7: 107-14. PMID 26722366 DOI: 10.7150/jca.13503  0.18
2012 Matei DV, Renne G, Pimentel M, Sandri MT, Zorzino L, Botteri E, De Cicco C, Musi G, Brescia A, Mazzoleni F, Tringali V, Detti S, de Cobelli O. Neuroendocrine differentiation in castration-resistant prostate cancer: a systematic diagnostic attempt. Clinical Genitourinary Cancer. 10: 164-73. PMID 22401754 DOI: 10.1016/j.clgc.2011.12.004  0.18
2004 Curigliano G, De Cobelli O, Sandri M, Zorzino L, Noberasco C, De Pas T, Scardino E, Formica V, Manzoni S, de Braud F. 385 A phase II trial to assess the efficacy and safety of gefitinib (Iressa™) in patients with metastatic hormone refractory prostate cancer (HRPC) who progressed on treatment with a luteinising hormone releasing hormone analogue (or post orchiectomy) plus an antiandrogen European Journal of Cancer Supplements. 2: 115-116. DOI: 10.1016/S1359-6349(04)80392-6  0.178
2014 Igidbashian S, Schettino MT, Boveri S, Barberis M, Sandri MT, Carinelli S, Cannone M, Sideri M. Tissue genotyping of 37 in situ and invasive cervical cancer with a concomitant negative HC2 HPV DNA test. Journal of Lower Genital Tract Disease. 18: 87-91. PMID 23959298 DOI: 10.1097/LGT.0b013e3182909f86  0.175
2015 Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT. Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma. Ecancermedicalscience. 9: 528. PMID 25987897 DOI: 10.3332/ecancer.2015.528  0.174
2014 De Simone C, Caldarola G, Coco V, Palumbo S, Pocino K, Sgambato A, Maiorino A, Corbi M, Sandri MT, Vendittelli F, Capoluongo E. Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment. Journal of the European Academy of Dermatology and Venereology : Jeadv. 28: 590-6. PMID 23506557 DOI: 10.1111/jdv.12140  0.174
2006 Pelosi G, Petrella F, Sandri MT, Spaggiari L, Galetta D, Viale G. A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. International Journal of Surgical Pathology. 14: 247-51. PMID 16959714 DOI: 10.1177/1066896906290657  0.173
2012 Origoni M, Carminati G, Rolla S, Clementi M, Sideri M, Sandri MT, Candiani M. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterine cervix in atypical squamous cells of undetermined significance (ASCUS) cytology. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 31: 2401-6. PMID 22382821 DOI: 10.1007/s10096-012-1582-1  0.171
2007 Serrano D, Macis D, Gandini S, Johansson H, Guerrieri-Gonzaga A, Mellgren G, Lien EA, Mariett F, Sandri M, Decensi A, Bonanni B. Correlation of low dose tamoxifen and its metabolites plasma level with Cyp 2D6, and SULT polymorphism; a pharmacogenetics study within a chemoprevention trial Journal of Clinical Oncology. 25: 503-503. DOI: 10.1200/JCO.2007.25.18_SUPPL.503  0.171
2021 Iacobone AD, Radice D, Sandri MT, Preti EP, Guerrieri ME, Vidal Urbinati AM, Pino I, Franchi D, Passerini R, Bottari F. Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence. Cancers. 13. PMID 34359566 DOI: 10.3390/cancers13153664  0.17
2012 Costa S, Venturoli S, Negri G, Sideri M, Preti M, Pesaresi M, Falasca A, Barbieri D, Zerbini M, Santini D, Sandri MT, Ghiringhello B, Caroppo Venturini N, Syrjänen S, Syrjänen K. Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases. Gynecologic Oncology. 124: 490-5. PMID 22188786 DOI: 10.1016/j.ygyno.2011.11.039  0.167
2000 Cardinale D, Sandri MT, Martinoni A, Tricca A, Civelli M, Lamantia G, Cinieri S, Martinelli G, Cipolla CM, Fiorentini C. Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. Journal of the American College of Cardiology. 36: 517-22. PMID 10933366 DOI: 10.1016/S0735-1097(00)00748-8  0.166
2011 Sideri M, Igidbashian S, Boveri S, Radice D, Casadio C, Spolti N, Sandri MT. Age distribution of HPV genotypes in cervical intraepithelial neoplasia Gynecologic Oncology. 121: 510-513. PMID 21396686 DOI: 10.1016/j.ygyno.2011.02.018  0.161
2020 Giannitto C, Sposta FM, Repici A, Vatteroni G, Casiraghi E, Casari E, Ferraroli GM, Fugazza A, Sandri MT, Chiti A, Luca B. Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab. La Radiologia Medica. PMID 32862406 DOI: 10.1007/s11547-020-01269-w  0.159
2007 Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Salvatici M, Veronesi G, Veglia F, Fiorentini C, Spaggiari L, Cipolla CM. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 115: 1339-44. PMID 17339553 DOI: 10.1161/CIRCULATIONAHA.106.647008  0.158
2009 Passerini R, Riggio D, Radice D, Bava L, Cassatella C, Salvatici M, Zorzino L, Sandri MT. Interference of antibiotic therapy on blood cultures time-to-positivity: Analysis of a 5-year experience in an oncological hospital European Journal of Clinical Microbiology and Infectious Diseases. 28: 95-98. PMID 18663498 DOI: 10.1007/s10096-008-0594-3  0.147
2016 Marzi MJ, Montani F, Carletti RM, Dezi F, Dama E, Bonizzi G, Sandri MT, Rampinelli C, Bellomi M, Maisonneuve P, Spaggiari L, Veronesi G, Bianchi F, Di Fiore PP, Nicassio F. Optimization and standardization of circulating MicroRNA detection for clinical application: The miR-test case Clinical Chemistry. 62: 743-754. DOI: 10.1373/clinchem.2015.251942  0.147
2005 Sandri MT, Salvatici M, Cardinale D, Zorzino L, Passerini R, Lentati P, Leon M, Civelli M, Martinelli G, Cipolla CM. N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction? Clinical Chemistry. 51: 1405-10. PMID 15932966 DOI: 10.1373/CLINCHEM.2005.050153  0.146
2020 De Cesare R, Morenghi E, Cirillo F, Ronchetti C, Canevisio V, Persico P, Baggiani A, Sandri MT, Levi-Setti PE. The Role of hCG Triggering Progesterone Levels: A Real-World Retrospective Cohort Study of More Than 8000 IVF/ICSI Cycles. Frontiers in Endocrinology. 11: 547684. PMID 33071968 DOI: 10.3389/fendo.2020.547684  0.146
2013 Halfon P, Lindemann ML, Raimondo A, Ravet S, Camus C, Khiri H, Pénaranda G, Sideri M, Sandri MT. HPV genotype distribution according to severity of cervical neoplasia using the Digene HPV genotyping LQ test. Archives of Virology. 158: 1143-9. PMID 23299934 DOI: 10.1007/s00705-012-1584-4  0.143
2015 Preti M, Igidbashian S, Costa S, Cristoforoni P, Mariani L, Origoni M, Sandri MT, Boveri S, Spolti N, Spinaci L, Sanvito F, Preti EP, Falasca A, Radici G, Micheletti L. VIN usual type-from the past to the future. Ecancermedicalscience. 9: 531. PMID 25987900 DOI: 10.3332/ecancer.2015.531  0.14
2007 Passerini R, Riggio D, Salvatici M, Zorzino L, Radice D, Sandri MT. Interchangeability of measurements of CA 19-9 in serum with four frequently used assays: An update Clinical Chemistry and Laboratory Medicine. 45: 100-104. PMID 17243924 DOI: 10.1515/CCLM.2007.003  0.139
2016 Marzi MJ, Montani F, Carletti RM, Dezi F, Dama E, Bonizzi G, Sandri MT, Rampinelli C, Bellomi M, Maisonneuve P, Spaggiari L, Veronesi G, Bianchi F, Di Fiore PP, Nicassio F. Optimization and Standardization of Circulating MicroRNA Detection for Clinical Application: The miR-Test Case. Clinical Chemistry. 62: 743-54. PMID 27127244 DOI: 10.1373/clinchem.2015.251942  0.139
2016 Ejegod D, Bottari F, Pedersen H, Sandri MT, Bonde J. The BD Onclarity HPV assay on SurePath collected samples meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening. Journal of Clinical Microbiology. PMID 27307461 DOI: 10.1128/JCM.00508-16  0.135
2016 Mariani L, Sandri MT, Preti M, Origoni M, Costa S, Cristoforoni P, Bottari F, Sideri M. HPV-Testing in follow-up of patients treated for CIN2+ lesions Journal of Cancer. 7: 107-114. DOI: 10.7150/jca.13503  0.132
2013 Rao A, Sandri MT, Sideri M, Young S, Sharma A, Behrens C. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 58: 161-7. PMID 23895930 DOI: 10.1016/j.jcv.2013.06.041  0.131
2016 Cosentino N, Marenzi G, Trinei M, Milazzo V, Moltrasio M, Cardinale D, Sandri MT, Twerenbold R, Boeddinghaus PJS, Cipolla C, Mueller C, Bartorelli A. CIRCULATING CYTOCHROME C IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Journal of the American College of Cardiology. 67: 481. DOI: 10.1016/S0735-1097(16)30482-X  0.13
2020 Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. European Journal of Endocrinology. 183: 381-387. PMID 32698147 DOI: 10.1530/EJE-20-0335  0.129
2016 Bottari F, Igidbashian S, Boveri S, Tricca A, Gulmini C, Sesia M, Spolti N, Sideri M, Landoni F, Sandri MT. HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women. Journal of Clinical Pathology. 70: 327-330. PMID 27672216 DOI: 10.1136/jclinpath-2016-204044  0.128
2011 Dellapasqua S, Bagnardi V, Bertolini F, Sandri M, Pastrello D, Cancello G, Montagna E, Goldhirsch A, Colleoni M. P191 Macrocytosis predicts response to metronomic chemotherapy with capecitabine and cyclophosphamide in combination with bevacizumab The Breast. 20: S41-S42. DOI: 10.1016/S0960-9776(11)70133-3  0.127
2006 Sandri MT, Lentati P, Benini E, Dell'Orto P, Zorzino L, Carozzi FM, Maisonneuve P, Passerini R, Salvatici M, Casadio C, Boveri S, Sideri M. Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples. Journal of Clinical Microbiology. 44: 2141-6. PMID 16757611 DOI: 10.1128/JCM.00049-06  0.127
2013 Halfon P, Sandri MT, Raimondo A, Ravet S, Khiri H, Sideri M, Penaranda G, Camus C, Mateos Lindemann ML. Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays. Bmc Infectious Diseases. 13: 499. PMID 24156822 DOI: 10.1186/1471-2334-13-499  0.126
2002 Bonanni B, Johansson H, Gandini S, Guerrieri-Gonzaga A, Torrisi R, Sandri MT, Cazzaniga M, Mora S, Robertson C, Lien EA, Decensi A. Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. Breast Cancer Research and Treatment. 69: 21-7. PMID 11759825 DOI: 10.1023/A:1012241505717  0.124
2016 Marenzi G, Cosentino N, Boeddinghaus J, Trinei M, Giorgio M, Milazzo V, Moltrasio M, Cardinale D, Sandri MT, Veglia F, Bonomi A, Kaech M, Twerenbold R, Nestelberger T, Reichlin T, et al. Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction. Circulation Research. PMID 27799252 DOI: 10.1161/CIRCRESAHA.116.309792  0.122
2021 Bottari F, Iacobone AD, Radice D, Preti EP, Preti M, Franchi D, Piana AF, Sandri MT, Passerini R. Anyplex II HPV test in detection and follow-up after surgical treatment of CIN2+ lesions. Journal of Medical Virology. 93: 6340-6346. PMID 33565607 DOI: 10.1002/jmv.26862  0.121
2015 Cardinale D, Sandri MT. Detection and monitoring of cardiotoxicity by using biomarkers: Pros and cons Progress in Pediatric Cardiology. 39: 77-84. DOI: 10.1016/J.PPEDCARD.2015.10.004  0.118
2016 Ejegod DM, Junge J, Franzmann M, Kirschner B, Bottari F, Sideri M, Sandri MT, Bonde J. Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples. Papillomavirus Research (Amsterdam, Netherlands). 2: 31-37. PMID 29074183 DOI: 10.1016/j.pvr.2016.01.003  0.118
2009 Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M. Typing of human papillomavirus in women with cervical lesions: Prevalence and distribution of different genotypes Journal of Medical Virology. 81: 271-277. PMID 19107962 DOI: 10.1002/jmv.21382  0.117
2022 Maira D, Duca L, Busti F, Consonni D, Salvatici M, Vianello A, Milani A, Guzzardella A, Di Pierro E, Aliberti S, Baldini IM, Bandera A, Blasi F, Cassinerio E, Cesari M, ... ... Sandri M, et al. The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study. American Journal of Hematology. 97: 1404-1412. PMID 36215667 DOI: 10.1002/ajh.26679  0.116
2002 Decensi A, Omodei U, Robertson C, Bonanni B, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Mora S, Sandri MT, Cazzaniga M, Franchi M, Pecorelli S. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation. 106: 1224-8. PMID 12208797 DOI: 10.1161/01.CIR.0000028463.74880.EA  0.115
2020 Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Research. 191: 9-14. PMID 32353746 DOI: 10.1016/j.thromres.2020.04.024  0.113
2018 Bottari F, Boveri S, Iacobone AD, Gulmini C, Igidbashian S, Cassatella MC, Landoni F, Sandri MT. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods. Infectious Diseases (London, England). 50: 554-559. PMID 29463149 DOI: 10.1080/23744235.2018.1441538  0.113
2014 Igidbashian S, Boveri S, Radice D, Casadio C, Spolti N, Sandri MT, Sideri M. Performance of self-sampled HPV test in comparison with liquid based cytology European Journal of Obstetrics Gynecology and Reproductive Biology. 177: 72-76. PMID 24768230 DOI: 10.1016/j.ejogrb.2014.03.028  0.112
2007 Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Martinelli G, Cipolla CM, Veglia F, Fiorentini C. Response to Letter Regarding Article, “Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition” Circulation. 115. DOI: 10.1161/CIRCULATIONAHA.107.695619  0.106
2019 Bottari F, Iacobone AD, Passerini R, Preti EP, Sandri MT, Cocuzza CE, Gary DS, Andrews JC. Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia: A Systematic Review. Obstetrics and Gynecology. PMID 31403602 DOI: 10.1097/AOG.0000000000003409  0.106
2015 Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecologic Oncology. 137: 47-54. PMID 25667973 DOI: 10.1016/j.ygyno.2015.01.551  0.106
2011 Igidbashian S, Boveri S, Spolti N, Radice D, Sandri MT, Sideri M. Self-collected human papillomavirus testing acceptability: Comparison of two self-sampling modalities Journal of Women's Health. 20: 397-402. PMID 21351869 DOI: 10.1089/jwh.2010.2189  0.103
2012 Mateos Lindemann ML, Rodriguez Dominguez MJ, Chacón De Antonio J, Sandri MT, Tricca A, Sideri M, Khiri H, Ravet S, Boyle S, Aldrich C, Halfon P. Analytical comparison of the cobas HPV test with hybrid capture 2 for the detection of high-risk HPV genotypes Journal of Molecular Diagnostics. 14: 65-70. PMID 22079749 DOI: 10.1016/j.jmoldx.2011.09.005  0.103
2021 Origoni M, Cristoforoni P, Mariani L, Costa S, Preti M, Sandri MT, Preti EP, Ghelardi A, Perino A. Extending Human Papillomavirus (HPV) vaccination beyond female adolescents and after treatment for high grade CIN: the Italian HPV Study Group (IHSG) review and position paper. European Review For Medical and Pharmacological Sciences. 24: 8510-8528. PMID 32894557 DOI: 10.26355/eurrev_202008_22648  0.102
2008 Mancuso P, Peccatori F, Rocca A, Calleri A, Antoniotti P, Rabascio C, Saronni L, Zorzino L, Sandri MT, Zubani A, Bertolini F. Circulating endothelial cell number and viability are reduced by exposure to high altitude. Endothelium : Journal of Endothelial Cell Research. 15: 53-8. PMID 18568945 DOI: 10.1080/10623320802092344  0.099
2021 Bottari F, Passerini R, Renne G, Guerrieri ME, Sandri MT, Li A, Orlandini A, Iacobone AD. Onclarity Performance in Human Papillomavirus DNA Detection in Formalin-Fixed Paraffin-Embedded Cervical Samples. Journal of Lower Genital Tract Disease. 25: 216-220. PMID 34176913 DOI: 10.1097/LGT.0000000000000613  0.097
2019 Bonde J, Bottari F, Parvu V, Pedersen H, Yanson K, Iacobone AD, Kodsi S, Landoni F, Vaughan L, Ejegod DM, Sandri MT. BAYESIAN ANALYSIS OF BASELINE RISK OF CIN2 AND ≥CIN3 BY HPV GENOTYPE IN A EUROPEAN REFERRAL COHORT. International Journal of Cancer. PMID 30895602 DOI: 10.1002/ijc.32291  0.097
2017 Mariani L, Igidbashian S, Sandri MT, Vici P, Landoni F. The clinical implementation of primary HPV screening. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 136: 266-271. PMID 28099686 DOI: 10.1002/ijgo.12065  0.097
2017 Sommariva E, D'Alessandra Y, Farina FM, Casella M, Cattaneo F, Catto V, Chiesa M, Stadiotti I, Brambilla S, Dello Russo A, Carbucicchio C, Vettor G, Riggio D, Sandri MT, Barbuti A, et al. MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy. Scientific Reports. 7: 4802. PMID 28684747 DOI: 10.1038/S41598-017-05001-Z  0.096
2022 Bottari F, Iacobone AD, Radice D, Preti EP, Preti M, Franchi D, Boveri S, Sandri MT, Passerini R. HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions. Diagnostics (Basel, Switzerland). 12. PMID 36292048 DOI: 10.3390/diagnostics12102359  0.096
2020 Bonde J, Bottari F, Iacobone AD, Cocuzza CE, Sandri MT, Bogliatto F, Khan KS, Ejegod DM, Gary DS, Andrews JC. Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review. Journal of Lower Genital Tract Disease. PMID 33105450 DOI: 10.1097/LGT.0000000000000573  0.095
2010 Halfon P, Benmoura D, Khiri H, Penaranda G, Blanc B, Riggio D, Sandri MT. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 47: 38-42. PMID 19939732 DOI: 10.1016/j.jcv.2009.10.013  0.094
2016 Lauri G, Rossi C, Rubino M, Cosentino N, Milazzo V, Marana I, Cabiati A, Moltrasio M, De Metrio M, Grazi M, Campodonico J, Assanelli E, Riggio D, Sandri MT, Bonomi A, et al. B-type natriuretic peptide levels in patients with pericardial effusion undergoing pericardiocentesis. International Journal of Cardiology. 212: 318-23. PMID 27057950 DOI: 10.1016/j.ijcard.2016.03.075  0.092
2019 Iacobone AD, Bottari F, Radice D, Preti EP, Franchi D, Vidal Urbinati AM, Boveri S, Passerini R, Sandri MT. Distribution of High-Risk Human Papillomavirus Genotypes and Multiple Infections in Preneoplastic and Neoplastic Cervical Lesions of Unvaccinated Women: A Cross-sectional Study. Journal of Lower Genital Tract Disease. 23: 259-264. PMID 31592973 DOI: 10.1097/LGT.0000000000000487  0.09
2017 Igidbashian S, Boveri S, Bottari F, Vidal Urbinati A, Preti E, Casadio C, Landoni F, Sideri M, Sandri MT. Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine. Journal of Lower Genital Tract Disease. 21: 4-8. PMID 27755229 DOI: 10.1097/LGT.0000000000000268  0.089
2019 Bottari F, Iacobone AD, Boveri S, Preti EP, Franchi D, Mariani L, Preti M, Landoni F, Passerini R, Sandri MT. Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions. Journal of Lower Genital Tract Disease. 23: 39-42. PMID 30371554 DOI: 10.1097/LGT.0000000000000441  0.088
2020 Cosentino N, Campodonico J, Pontone G, Guglielmo M, Trinei M, Sandri MT, Riggio D, Baggiano A, Milazzo V, Moltrasio M, Muscogiuri G, Bonomi A, Barbieri S, Assanelli E, Lauri G, et al. Iron deficiency in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. International Journal of Cardiology. 300: 14-19. PMID 31399299 DOI: 10.1016/j.ijcard.2019.07.083  0.087
2021 Vallejo-Garcia JL, Balia L, Raimondi R, Rustioni G, Camesasca FI, Borgia A, Fossati G, Confalonieri F, Legrottaglie EF, Casari E, Sandri MT, Vinciguerra P. Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptoms. European Journal of Ophthalmology. 11206721211056594. PMID 34761693 DOI: 10.1177/11206721211056594  0.086
2018 Introcaso G, Nafi M, Bonomi A, L'Acqua C, Salvi L, Ceriani R, Carcione D, Cattaneo A, Sandri MT. Improvement of neutrophil gelatinase-associated lipocalin sensitivity and specificity by two plasma measurements in predicting acute kidney injury after cardiac surgery. Biochemia Medica. 28: 030701. PMID 30429668 DOI: 10.11613/BM.2018.030701  0.085
2019 Origoni M, Cristoforoni P, Mariani L, Costa S, Preti M, Sandri MT, Preti EP, Ghelardi A, Perino A. [HPV vaccination: not only female adolescents and not only prophylactic. Review and position paper of the Italian HPV Study Group (IHSG)]. Minerva Ginecologica. 71: 442-459. PMID 31741364 DOI: 10.23736/S0026-4784.19.04443-5  0.083
2020 Loglio A, Iavarone M, Facchetti F, Di Paolo D, Perbellini R, Lunghi G, Ceriotti F, Galli C, Sandri MT, Viganò M, Sangiovanni A, Colombo M, Lampertico P. The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy. Liver International : Official Journal of the International Association For the Study of the Liver. 40: 1987-1996. PMID 32301212 DOI: 10.1111/liv.14475  0.083
2015 Bottari F, Sideri M, Gulmini C, Igidbashian S, Tricca A, Casadio C, Carinelli S, Boveri S, Ejegod D, Bonde J, Sandri MT. Comparison of Onclarity Human Papillomavirus (HPV) Assay with Hybrid Capture II HPV DNA Assay for Detection of Cervical Intraepithelial Neoplasia Grade 2 and 3 Lesions. Journal of Clinical Microbiology. 53: 2109-14. PMID 25903574 DOI: 10.1128/JCM.00246-15  0.083
2021 Mazziotti G, Lavezzi E, Brunetti A, Mirani M, Favacchio G, Pizzocaro A, Sandri MT, Di Pasquale A, Voza A, Ciccarelli M, Lania AG. Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19. Journal of Endocrinological Investigation. 44: 2285-2293. PMID 33666876 DOI: 10.1007/s40618-021-01535-2  0.081
2016 Bianchi S, Boveri S, Igidbashian S, Amendola A, Urbinati AM, Frati ER, Bottari F, Colzani D, Landoni F, Tanzi E, Sideri M, Sandri MT. Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity. Archives of Gynecology and Obstetrics. 294: 1227-1233. PMID 27501926 DOI: 10.1007/s00404-016-4167-x  0.08
2015 Allweis TM, Strauss L, Malyutin Z, Kapov-Kagan AB, Novikov I, Bevers TB, Iacobelli S, Sandri MT, Bitterman A, Engelman P, Piura B, Rosenberg M, Yahalom G. An Autoantibody Based Protein Microarray Blood Test to Enhance the Specificity of a Negative Screening Mammogram Advances in Breast Cancer Research. 4: 22-38. DOI: 10.4236/ABCR.2015.41003  0.076
2021 Levi R, Ubaldi L, Pozzi C, Angelotti G, Sandri MT, Azzolini E, Salvatici M, Savevski V, Mantovani A, Rescigno M. The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients. Communications Medicine. 1: 32. PMID 35072166 DOI: 10.1038/s43856-021-00032-0  0.075
2021 Levi R, Ubaldi L, Pozzi C, Angelotti G, Sandri MT, Azzolini E, Salvatici M, Savevski V, Mantovani A, Rescigno M. The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients. Communications Medicine. 1: 32. PMID 35072166 DOI: 10.1038/s43856-021-00032-0  0.075
2015 Huh W, Behrens C, Monsonego J, Cox T, Sandri M, Yap P, Franco E. Relative prevalence of high risk HPV genotypes in a US population: Insights before rollout of the next generation 9-valent HPV vaccine Gynecologic Oncology. 137: 16. DOI: 10.1016/J.YGYNO.2015.01.037  0.074
2020 Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt J, Sacco C, Alexia B, Sandri M, Barco S. Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy Journal of Vascular Surgery: Venous and Lymphatic Disorders. 8: 1119. DOI: 10.1016/j.jvsv.2020.08.013  0.074
2010 Franchi D, Sandri M, Boveri S, Ronzoni S, Aletti G, Radice D, Sideri M. OP31.04: Ultrasound imaging compared to a multivariate predictive algorithm combining HE4 and CA 125 (ROMA®) in the pre-operative assessment of adnexal masses: preliminary results Ultrasound in Obstetrics and Gynecology. 36: 143-143. DOI: 10.1002/uog.8219  0.068
2020 Personeni N, Mineri R, D'Alessio A, Cammarota A, Michelini A, Bozzarelli S, Smiroldo V, Pressiani T, Giordano L, Sandri M, Santoro A, Rimassa L. 1838P Do irinotecan (IRI) dose reductions driven by UGT1A1*28 genotyping prevent IRI-related severe neutropenia? A real-world study Annals of Oncology. 31: S1056. DOI: 10.1016/j.annonc.2020.08.1485  0.065
1997 Bonanni B, Decensi A, Travaglini R, Guerrieri Gonazaga A, Tessadrelli A, Sandri M, Farante G, Bettega D, Robertson C, Costa A. Low-dose tamoxifen trial in healthy women European Journal of Cancer. 33: S10-S11. DOI: 10.1016/S0959-8049(97)84415-2  0.065
2000 Bertolini F, Agazzi A, Peccatori F, Martinelli G, Sandri MT. The absence of swirling in platelet concentrates is highly predictive of poor posttransfusion platelet count increments and increased risk of a transfusion reaction. Transfusion. 40: 121-2. PMID 10644824 DOI: 10.1046/j.1537-2995.2000.4001121.x  0.064
2014 Passerini R, Cassatella MC, Salvatici M, Bottari F, Mauro C, Radice D, Sandri MT. Recovery and time to growth of isolates in blood culture bottles: comparison of BD Bactec Plus Aerobic/F and BD Bactec Plus Anaerobic/F bottles. Scandinavian Journal of Infectious Diseases. 46: 288-93. PMID 24460080 DOI: 10.3109/00365548.2013.876510  0.059
2011 Cardinale D, Colombo A, Torrisi R, Sandri MT, Civelli M, Salvatici M, Lamantia G, Colombo N, Cortinovis S, Dessanai MA, Nolè F, Veglia F, Cipolla CM. Reply to S. Goel et al and P.A. Kavsak et al Journal of Clinical Oncology. 29: e178-e179. DOI: 10.1200/JCO.2010.32.8807  0.053
2021 Sandri MT, Azzolini E, Torri V, Carloni S, Pozzi C, Salvatici M, Tedeschi M, Castoldi M, Mantovani A, Rescigno M. SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy. Scientific Reports. 11: 12312. PMID 34112899 DOI: 10.1038/s41598-021-91773-4  0.046
1982 Schaefer K, Ryzlewicz T, Sandri M, von Bernewitz S, von Herrath D. Effect of hemofiltration on acid-base status and ventilation. Contributions to Nephrology. 32: 69-76. PMID 6813023 DOI: 10.1159/000406907  0.045
2018 Magini A, Farina S, Riggio D, Sandri MT, Agostoni P. ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure. European Journal of Heart Failure. 20: 1494-1495. PMID 30052313 DOI: 10.1002/ejhf.1246  0.041
2009 Noberasco C, Spitaleri G, Mancuso P, Zorzino L, Radice D, Milani A, Rocca A, Bertolini F, Sandri MT, Curigliano G, de Pas T, Jemos C, Omodeo Salè E, Boselli S, de Braud F. Safety, tolerability and biological effects of long-term metronomic administration of non-cytotoxic anti-angiogenic agents. Oncology. 77: 358-65. PMID 20068365 DOI: 10.1159/000275830  0.036
2007 Passerini R, Moretti L, Riggio D, Urso V, Sandri M. INFLUENZA DELLA ANTIBIOTICOTERAPIA SUL DIFFERENTIAL TIME TO POSITIVITY (DTP) NELLE BATTERIEMIE CVC-CORRELATE Microbiologia Medica. 22. DOI: 10.4081/mm.2007.2748  0.036
2015 Jones RL, Sandri MT. Cardio-oncology: a special focus issue from Future Oncology. Future Oncology (London, England). 11: 1993-4. PMID 26198823 DOI: 10.2217/fon.15.126  0.032
2015 Jones RL, Sandri MT. Cardio-oncology: A special focus issue from Future Oncology Future Oncology. 11: 1993-1994. DOI: 10.2217/fon.15.126  0.032
1987 Gerli GC, Mongiat R, Sandri MT, Agostoni A, Gualandri V, Orsini GB, Buso GP, Moschini G, Carpani G, Marini F. Antioxidant system and serum trace elements in α-thalassaemia and Hb Lepore trait European Journal of Haematology. 39: 23-27. PMID 3653368 DOI: 10.1111/j.1600-0609.1987.tb00158.x  0.029
2019 Salvatici M, Leone F, Carnesalli D, Anelli M, Barbieri B, Sandri M. Thyroid hormones reference ranges check from local population database Clinica Chimica Acta. 493: S332-S333. DOI: 10.1016/J.CCA.2019.03.720  0.023
2009 Zhong Q, Luo H, Yi T, Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, Mauro Gd, Cerchia L, Riccio P, Baumhoer D, Condorelli G, Terracciano L, Franciscis Vd, ... ... Sandri MT, et al. Subject Index Vol. 77, 2009 Oncology. 77: 417-418. DOI: 10.1159/000287228  0.023
2009 Zhong Q, Luo H, Yi T, Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, Mauro Gd, Cerchia L, Riccio P, Baumhoer D, Condorelli G, Terracciano L, Franciscis Vd, ... ... Sandri MT, et al. Contents Vol. 77, 2009 Oncology. 77. DOI: 10.1159/000287231  0.012
Hide low-probability matches.